|
|
|
|
|
|
|
28.05.25 - 14:03
|
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference (GlobeNewswire EN)
|
|
|
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director, chief executive officer, and president, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference, on Wednesday, June 11, 2025, at 2:00 p.m. ET....
|
|
|
|
|
|
|
13.05.25 - 22:45
|
What Analysts Are Saying About Axogen Stock (Benzinga)
|
|
|
Latest Ratings for AXGN
DateFirmActionFromTo Nov 2021JMP SecuritiesMaintainsMarket Outperform May 2021Canaccord GenuityMaintainsHold Feb 2021Canaccord GenuityMaintainsHold
View More Analyst Ratings for AXGN
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
|
|
08.05.25 - 13:09
|
Axogen, Inc. Reports 2025 First Quarter Financial Results (GlobeNewswire EN)
|
|
|
ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31, 2025....
|
|
|
24.04.25 - 14:06
|
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025 (GlobeNewswire EN)
|
|
|
ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2025 first quarter financial results on Thursday, May 8, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release....
|
|
|
|
|
|
|
|
|
|
|
25.02.25 - 13:12
|
Axogen, Inc. To Host Analyst & Investor Day on March 4th (GlobeNewswire EN)
|
|
|
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, will hold its Analyst & Investor Day on March 4, 2025, between 9am-12pm Eastern....
|
|
|
|
|
11.02.25 - 23:00
|
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 (GlobeNewswire EN)
|
|
|
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2024 fourth quarter and full year financial results on Tuesday, February 25, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release....
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
